As medications like Ozempic transform the health of millions of Americans, some families are discovering a surprising side ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

People who take weight-loss drugs hoping to achieve the impressive results observed in large clinical trials may need to ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

Researchers found that injectable GLP-1 receptor agonists for obesity tended to yield smaller reductions in weight in ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Three dads share how their bodies and family relationships have changed since they began taking GLP-1 weight loss medications ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Last week, Australia’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a ...

GLP-1 investors haven’t gained as much as expected from others’ losses. Since the FDA approved Wegovy, also known as ...

A recent study revealed that popular weight-loss drugs GLP-1 such as Ozempic, Wegovy and Zepbound produce lower weight loss ...